174 related articles for article (PubMed ID: 30419850)
1. Are comorbidities associated with long-term survival of lung cancer? A population-based cohort study from French cancer registries.
Seigneurin A; Delafosse P; Trétarre B; Woronoff AS; Velten M; Grosclaude P; Guizard AV; Lapôtre-Ledoux B; Bara S; Molinié F; Colonna M
BMC Cancer; 2018 Nov; 18(1):1091. PubMed ID: 30419850
[TBL] [Abstract][Full Text] [Related]
2. Impact of comorbidity on survival by tumour location: Breast, colorectal and lung cancer (2000-2014).
Parés-Badell O; Banqué M; Macià F; Castells X; Sala M
Cancer Epidemiol; 2017 Aug; 49():66-74. PubMed ID: 28586708
[TBL] [Abstract][Full Text] [Related]
3. Comorbidity Assessment Using Charlson Comorbidity Index and Simplified Comorbidity Score and Its Association With Clinical Outcomes During First-Line Chemotherapy for Lung Cancer.
Singh N; Singh PS; Aggarwal AN; Behera D
Clin Lung Cancer; 2016 May; 17(3):205-213.e1. PubMed ID: 26589440
[TBL] [Abstract][Full Text] [Related]
4. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
5. Trends in net survival lung cancer in six European Latin countries: results from the SUDCAN population-based study.
Bordoni A; Uhry Z; Antunes L;
Eur J Cancer Prev; 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study():S70-S76. PubMed ID: 28005608
[TBL] [Abstract][Full Text] [Related]
6. Charlson Comorbidity Index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation.
Simon TG; Beland MD; Machan JT; Dipetrillo T; Dupuy DE
Eur J Radiol; 2012 Dec; 81(12):4167-72. PubMed ID: 22835876
[TBL] [Abstract][Full Text] [Related]
7. Comorbidity in Patients With Small-Cell Lung Cancer: Trends and Prognostic Impact.
Aarts MJ; Aerts JG; van den Borne BE; Biesma B; Lemmens VE; Kloover JS
Clin Lung Cancer; 2015 Jul; 16(4):282-91. PubMed ID: 25572007
[TBL] [Abstract][Full Text] [Related]
8. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer.
Chansky K; Sculier JP; Crowley JJ; Giroux D; Van Meerbeeck J; Goldstraw P;
J Thorac Oncol; 2009 Jul; 4(7):792-801. PubMed ID: 19458556
[TBL] [Abstract][Full Text] [Related]
9. Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer.
Birim O; Kappetein AP; Goorden T; van Klaveren RJ; Bogers AJ
Ann Thorac Surg; 2005 Sep; 80(3):1021-6. PubMed ID: 16122477
[TBL] [Abstract][Full Text] [Related]
10. The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients.
Lüchtenborg M; Jakobsen E; Krasnik M; Linklater KM; Mellemgaard A; Møller H
Eur J Cancer; 2012 Dec; 48(18):3386-95. PubMed ID: 22795582
[TBL] [Abstract][Full Text] [Related]
11. Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer.
Zhao L; Leung LH; Wang J; Li H; Che J; Liu L; Yao X; Cao B
BMC Pulm Med; 2017 Aug; 17(1):112. PubMed ID: 28806935
[TBL] [Abstract][Full Text] [Related]
12. Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer.
Moro-Sibilot D; Aubert A; Diab S; Lantuejoul S; Fourneret P; Brambilla E; Brambilla C; Brichon PY
Eur Respir J; 2005 Sep; 26(3):480-6. PubMed ID: 16135732
[TBL] [Abstract][Full Text] [Related]
13. Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods.
Roche L; Danieli C; Belot A; Grosclaude P; Bouvier AM; Velten M; Iwaz J; Remontet L; Bossard N
Int J Cancer; 2013 May; 132(10):2359-69. PubMed ID: 22961565
[TBL] [Abstract][Full Text] [Related]
14. Improvement in population-based survival of stage IV NSCLC due to increased use of chemotherapy.
Aarts MJ; van den Borne BE; Biesma B; Kloover JS; Aerts JG; Lemmens VE
Int J Cancer; 2015 Mar; 136(5):E387-95. PubMed ID: 25219898
[TBL] [Abstract][Full Text] [Related]
15. Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study.
Weberpals J; Jansen L; Haefeli WE; Hoffmeister M; Wolkewitz M; Herk-Sukel MPPV; Vissers PAJ; Brenner H
Sci Rep; 2017 Jun; 7(1):2911. PubMed ID: 28588274
[TBL] [Abstract][Full Text] [Related]
16. Impact of comorbidity index on morbidity and survival in non-small cell lung cancer.
Otake S; Ohtsuka T; Asakura K; Kamiyama I; Kohno M
Asian Cardiovasc Thorac Ann; 2016 Jan; 24(1):30-3. PubMed ID: 26567555
[TBL] [Abstract][Full Text] [Related]
17. Influence of medical comorbidities on the presentation and outcomes of stage I-III non-small-cell lung cancer.
Ahn DH; Mehta N; Yorio JT; Xie Y; Yan J; Gerber DE
Clin Lung Cancer; 2013 Nov; 14(6):644-50. PubMed ID: 23886797
[TBL] [Abstract][Full Text] [Related]
18. Impact of Comorbidities on Survival in Gastric, Colorectal, and Lung Cancer Patients.
Morishima T; Matsumoto Y; Koeda N; Shimada H; Maruhama T; Matsuki D; Nakata K; Ito Y; Tabuchi T; Miyashiro I
J Epidemiol; 2019 Mar; 29(3):110-115. PubMed ID: 30012908
[TBL] [Abstract][Full Text] [Related]
19. Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.
Habbous S; Harland LT; La Delfa A; Fadhel E; Xu W; Liu FF; Goldstein D; Waldron J; Huang SH; O'Sullivan B; Liu G
Head Neck; 2014 Jun; 36(6):802-10. PubMed ID: 23616414
[TBL] [Abstract][Full Text] [Related]
20. Population-based survival from cancers having a poor prognosis in Mumbai (Bombay), India.
Yeole BB; Kumar AV
Asian Pac J Cancer Prev; 2004; 5(2):175-82. PubMed ID: 15244521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
